Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Income Statement [Abstract] | ||||
| General and administrative costs, to related parties | $ 784,390 | $ 12,000 | $ 808,390 | $ 41,691 |
| Research and development costs, to Theradex | $ 804 | $ 40,225 | $ 804 | $ 104,840 |
| X | ||||||||||
- Definition Represents the amount of research and development cost incurred in relation to related parties during the period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party. No definition available.
|